Why is FDA approval withheld?
Despite decades of medical research establishing the curative power of DMSO and its free radical scavenging antioxidant properties, the FDA has not granted broad approval for its use. A close examination of the practices and policies of the FDA consistently lead to three explanatory theories. 1) In several of the instances where research has established the medical effectiveness of DMSO, the researchers have been unable to determine the exact process by which the effectiveness was achieved. In other words, they know it works but they don’t all the reasons why. 2) The topical application of DMSO is followed, shortly thereafter, by a distinct “garlic like” taste in one’s mouth. The inability of researchers to develop a placebo which emulates this characteristic prevents the satisfactory completion of a “double blind” study. The lack of a “double blind” study has previously been cited by the FDA as reason enough to withhold approval of a drug. 3) Sheer economics work against the widesprea
